Difference between revisions of "GanA"
Line 35: | Line 35: | ||
=== Basic information === | === Basic information === | ||
− | * '''Locus tag:''' | + | * '''Locus tag:''' BSU34130 |
===Phenotypes of a mutant === | ===Phenotypes of a mutant === | ||
Line 80: | Line 80: | ||
* '''Swiss prot entry:''' [http://www.uniprot.org/uniprot/O07012 O07012] | * '''Swiss prot entry:''' [http://www.uniprot.org/uniprot/O07012 O07012] | ||
− | * '''KEGG entry:''' [http://www.genome.jp/dbget-bin/www_bget?bsu+ | + | * '''KEGG entry:''' [http://www.genome.jp/dbget-bin/www_bget?bsu+BSU34130] |
* '''E.C. number:''' [http://www.expasy.org/enzyme/3.2.1.23 3.2.1.23] 3 | * '''E.C. number:''' [http://www.expasy.org/enzyme/3.2.1.23 3.2.1.23] 3 |
Revision as of 13:54, 3 June 2009
- Description: beta-galactosidase
Gene name | lacA |
Synonyms | yvfN |
Essential | no |
Product | beta-galactosidase |
Function | unknown |
MW, pI | 79 kDa, 5.704 |
Gene length, protein length | 2061 bp, 687 aa |
Immediate neighbours | yvfO, yvfM |
Get the DNA and protein sequences (Barbe et al., 2009) | |
Genetic context This image was kindly provided by SubtiList
|
Contents
The gene
Basic information
- Locus tag: BSU34130
Phenotypes of a mutant
Database entries
- DBTBS entry: [1]
- SubtiList entry: [2]
Additional information
The protein
Basic information/ Evolution
- Catalyzed reaction/ biological activity: Hydrolysis of terminal non-reducing beta-D-galactose residues in beta-D-galactosides (according to Swiss-Prot)
- Protein family: glycosyl hydrolase 42 family (according to Swiss-Prot)
- Paralogous protein(s):
Extended information on the protein
- Kinetic information:
- Domains:
- Modification:
- Cofactor(s):
- Effectors of protein activity:
- Interactions:
- Localization:
Database entries
- Structure:
- Swiss prot entry: O07012
- KEGG entry: [3]
- E.C. number: 3.2.1.23 3
Additional information
Expression and regulation
- Operon:
- Regulation:
- Regulatory mechanism:
- Additional information:
Biological materials
- Mutant:
- Expression vector:
- lacZ fusion:
- GFP fusion:
- two-hybrid system:
- Antibody: